Brian M. Hahn
2016
In 2016, Brian M. Hahn earned a total compensation of $670.9K as Chief Financial Officer at GlycoMimetics, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,410 |
|---|---|
| Option Awards | $212,550 |
| Salary | $324,000 |
| Other | $3,975 |
| Total | $670,935 |
Hahn received $324K in salary, accounting for 48% of the total pay in 2016.
Hahn also received $130.4K in non-equity incentive plan, $212.6K in option awards and $4K in other compensation.
Rankings
In 2016, Brian M. Hahn's compensation ranked 10,078th out of 14,075 executives tracked by ExecPay. In other words, Hahn earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,078 out of 14,075 | 28th |
Division Manufacturing | 3,895 out of 5,489 | 29th |
Major group Chemicals And Allied Products | 1,372 out of 1,895 | 28th |
Industry group Drugs | 1,097 out of 1,538 | 29th |
Industry Pharmaceutical Preparations | 860 out of 1,176 | 27th |
Source: SEC filing on April 20, 2017.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2016.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019